 |
| Vaccination |
Last updated: Oct 09, 2008 |
 |
|
 |
| |
In humans, the most rapid period of brain development begins in the third trimester and continues over the first two years of extra uterine life. (By then, brain development is 80 percent complete.) Until randomized controlled trials demonstrate the safety of giving vaccines during this time of life, it would be prudent not to give any vaccinations to children until they are 2-years-old.
From a risk-benefit perspective, there is growing evidence that the risk of neurologic and autoimmune diseases from vaccinations outweigh the benefits of avoiding the childhood infections that they prevent. An exception is hepatitis B vaccine for infants whose mothers test positive for this disease.
A user-friendly vaccination schedule prohibits any vaccines that contain thimerosal, which is 50 percent mercury. Flu vaccines contain thimerosal, which is reason enough to avoid them.
One should also avoid vaccines that contain live viruses. This includes the combined measles, mumps, and rubella (MMR) vaccine; chickenpox (varicella) vaccine; and the live-virus polio (Sabin) vaccine. This stricture would not apply to the smallpox vaccine (also a live-virus one), if a terrorist-instigated outbreak of smallpox should occur.
Finally, a user-friendly vaccination schedule requires that vaccinations, after the age of two, be given no more than once every six months, one at a time, in order to allow the immune system sufficient time to recover and stabilize between shots.
Which vaccines should be put on this schedule (among those that do not contain live viruses or thimerosal) is not entirely clear. The top four would be:
Pertussis (acelluar -- aP -- not whole cell) vaccine. Diphtheria (D) vaccine. Tetanus (T) vaccine (the first three on this list are to be given separately, not together, as is usually the case). The Salk polio vaccine, with an inactivated (dead) virus, one that is cultured in human cells, not monkey kidney cells.
Perhaps, it should only contain these four vaccines. A good case can be made for avoiding the three other newer vaccines on the CDC's schedule: The hepatitis B, pneumococcal conjugate (PCV7) and Hemophilus influenzae type b (Hib) vaccines. [Donald W. Miller, Jr., MD]
|
|
 |
|
 |
Vaccination can help with the following: | |  | | | | Tumors, Malignant | Ovarian Cancer | Christine Sable was not diagnosed with ovarian cancer until it was already advanced; a scenario far too common with this particular type of cancer.
After enduring surgery and an aggressive round of chemotherapy, doctors had nothing else to offer her but more chemotherapy. Instead, Sable sought out, and in 2004 was accepted into, a Phase I clinical research study of an ovarian cancer vaccine developed by Kunle Odunsi, MD, PhD, Surgeon in Gynecologic Oncology and Co-Leader of the Tumor Immunology and Immunotherapy Program at Roswell Park Cancer Institute in Buffalo, New York.
According to a report in ScienceDaily, the vaccine "is designed to trigger an immune response in the significant number of women who have tumors that test positive for the antigen NY-ESO-1."
The report states that Sable's immune system "responded so strongly to the first five doses of vaccine that she received another five, then another five, each time experiencing a better response—with no side effects. Now 49 and still cancer-free, she returns to Roswell Park just once a year for continued monitoring." [ScienceDaily Apr. 7, 2008] |
|
| |  | |  |
KEY |  | Likely to help |
|
 |